Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer:National Surgical Adjuvant Breast and Bowel Project Protocol B-27.
By H. Bear, S. Anderson, Roy E. Smith, C. Geyer, E. Mamounas, B. Fisher, Ann M. Brown, A. Robidoux, R. Margolese, M. Kahlenberg and 4 more. Journal of Clinical Oncology, 2006
959 citations recorded by the source corpus.
Subfields: Cancer Research, Oncology, Psychiatry and Mental health
View Paper: https://www.semanticscholar.org/paper/a0961c98ab6fdf92b0680d5494fd1b897a5639ac
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- M. Untch
- Carsten Denkert
- J. Blohmer
- P. Rastogi
- S. Costa
- H. Eidtmann
- G. Konecny
- Peter A. Fasching
Citations in the corpus
- Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27. (2008, background): “Preoperative therapy, initially used only for locally advanced breast cancer, has become more common for patients with operable disease.(1-17) This allows more individuals to undergo breast-conserving procedures and provides for observation of response to treatment.”
- Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes. (2012, result): “The prognostic importance of involved lymph nodes after neoadjuvant chemotherapy has already been stressed by others.(36,37) However, withthelargesamplesize,wecannowdemonstratethatthesmallgroupof patientswithypT0/isypN tumorshasaconsiderablyinferiorprognosis, comparable to that of patients with tumo”